Jeremy Clark, MD
Ophthalmology · Louisville, KYNPI 1073838850
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $106,768 of the $130,863 with a category attached, or 81.6%. Amgen accounts for 96.5% of it on its own, with 16 other manufacturers making up the rest. Among ophthalmology clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 246 payments — averaging $531.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$126K
- Novartis$3K
- Alcon$266
- Axogen$185
- Glaukos Corporation$142
- NEW World Medical,inc.$131
- plus $634 from 11 others
Across 1 payment — averaging $197.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$198
What the payments were for
- Consulting fees$9,5007%
- Speaking & faculty fees$106,76882%
- Travel & lodging$7,4576%
- Food & beverage$7,1295%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 218 | $126,246 |
| Novartis | 4 | $3,259 |
| Alcon | 4 | $266 |
| Axogen | 4 | $185 |
| Glaukos Corporation | 1 | $142 |
| NEW World Medical,inc. | 1 | $131 |
| Kala Pharmaceuticals, Inc. | 1 | $120 |
| AbbVie | 1 | $108 |
| Mallinckrodt Enterprises LLC | 1 | $105 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $85 |
| ANI Pharmaceuticals, Inc. | 1 | $75 |
| Biotissue Holdings Inc. | 4 | $41 |
| Stryker | 1 | $36 |
| Merz Pharmaceuticals, LLC | 1 | $21 |
| Merz North America, Inc. | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $14 |
| Pacira Pharmaceuticals Incorporated | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TEPEZZA$122,050
- iStent Trabecular Micro-Bypass System Model iS3$142
- PanOptix$128
- SIMBRINZA$123
- Rocklatan$123
- Rhopressa$123
- INVELTYS$120
- XEN$108
- ACTHAR$105
- AVANCE NERVE GRAFT$101
How this compares
$130,863 in reported general payments places this provider in the 95th percentile of 216 ophthalmology providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErythromycinErythromycin Base | 214 | $2,033 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 69 | $865 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 155 | $455 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $93 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Louisville
- Guruprasad PattarLouisville$36K
- Gary FoulksLouisville$16K
- Christopher ComptonLouisville$13K
- Inder SingalLouisville$9K
- Rishi KumarLouisville$8K
- Frank BurnsLouisville$8K
- Steven BloomLouisville$6K
- Sharmini BalakrishnanLouisville$6K
- Sergei DmitrukLouisville$5K
- Lawrence TenkmanLouisville$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.